These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10836493)

  • 1. Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mice tested in the light-dark box.
    Maldonado E; Navarro JF
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Apr; 24(3):463-72. PubMed ID: 10836493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice.
    Ferraz-de-Paula V; Stankevicius D; Ribeiro A; Pinheiro ML; Rodrigues-Costa EC; Florio JC; Lapachinske SF; Moreau RL; Palermo-Neto J
    Braz J Med Biol Res; 2011 May; 44(5):428-37. PubMed ID: 21503414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiogenic-like activity of 3,4-methylenedioxy-methamphetamine ("Ecstasy") in the social interaction test is accompanied by an increase of c-fos expression in mice amygdala.
    Navarro JF; Rivera A; Maldonado E; Cavas M; de la Calle A
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):249-54. PubMed ID: 14751419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral profile of 3,4-methylenedioxy-methamphetamine (MDMA) in agonistic encounters between male mice.
    Navarro JF; Maldonado E
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Feb; 23(2):327-34. PubMed ID: 10368873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and subchronic effects of MDMA ("ecstasy") on anxiety in male mice tested in the elevated plus-maze.
    Navarro JF; Maldonado E
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1151-4. PubMed ID: 12452538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats.
    Morley KC; McGregor IS
    Eur J Pharmacol; 2000 Nov; 408(1):41-9. PubMed ID: 11070182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and neurochemical consequences of multiple MDMA administrations in the rat: role of individual differences in anxiety-related behavior.
    Ludwig V; Mihov Y; Schwarting RK
    Behav Brain Res; 2008 May; 189(1):52-64. PubMed ID: 18241937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of impulsivity and novelty-seeking to the acquisition and maintenance of MDMA self-administration.
    Bird J; Schenk S
    Addict Biol; 2013 Jul; 18(4):654-64. PubMed ID: 22784256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice.
    Risbrough VB; Masten VL; Caldwell S; Paulus MP; Low MJ; Geyer MA
    Neuropsychopharmacology; 2006 Nov; 31(11):2349-58. PubMed ID: 16855533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral profiles in rats distinguish among "ecstasy," methamphetamine and 2,5-dimethoxy-4-iodoamphetamine: Mixed effects for "ecstasy" analogues.
    Quinteros-Muñoz D; Sáez-Briones P; Díaz-Véliz G; Mora-Gutiérrez S; Rebolledo-Fuentes M; Cassels BK
    Behav Neurosci; 2010 Oct; 124(5):662-76. PubMed ID: 20939666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased sensitivity to the acute effects of MDMA ("ecstasy") in female rats.
    Palenicek T; Votava M; Bubenikova V; Horacek J
    Physiol Behav; 2005 Nov; 86(4):546-53. PubMed ID: 16233904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ritanserin-sensitive receptors modulate the prosocial and the anxiolytic effect of MDMA derivatives, DOB and PMA, in zebrafish.
    Ponzoni L; Sala M; Braida D
    Behav Brain Res; 2016 Nov; 314():181-9. PubMed ID: 27506653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral sensitization to 3,4-methylenedioxymethamphetamine is long-lasting and modulated by the context of drug administration.
    Ball KT; Klein JE; Plocinski JA; Slack R
    Behav Pharmacol; 2011 Dec; 22(8):847-50. PubMed ID: 21979834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat.
    Ho YJ; Pawlak CR; Guo L; Schwarting RK
    Behav Brain Res; 2004 Mar; 149(2):135-44. PubMed ID: 15129777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents.
    Gatch MB; Dolan SB; Forster MJ
    Behav Pharmacol; 2016 Sep; 27(6):497-505. PubMed ID: 27028902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute behavioral effects of co-administration of mephedrone and MDMA in mice.
    Budzynska B; Michalak A; Frankowska M; Kaszubska K; Biała G
    Pharmacol Rep; 2017 Apr; 69(2):199-205. PubMed ID: 28073060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization to MDMA locomotor effects and changes in the functionality of 5-HT(2A) and D₂ receptors in mice.
    Varela MJ; Brea J; Loza MI; Maldonado R; Robledo P
    Behav Pharmacol; 2011 Aug; 22(4):362-9. PubMed ID: 21712712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats.
    Walker QD; Williams CN; Jotwani RP; Waller ST; Francis R; Kuhn CM
    Psychopharmacology (Berl); 2007 Jan; 189(4):435-45. PubMed ID: 17019566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4-methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations.
    Frenzilli G; Ferrucci M; Giorgi FS; Blandini F; Nigro M; Ruggieri S; Murri L; Paparelli A; Fornai F
    Behav Pharmacol; 2007 Sep; 18(5-6):471-81. PubMed ID: 17762515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (+/-)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: a comparison of single vs once per week treatment for 5 weeks.
    Skelton MR; Able JA; Grace CE; Herring NR; Schaefer TL; Gudelsky GA; Vorhees CV; Williams MT
    Neuropharmacology; 2008 Dec; 55(7):1121-30. PubMed ID: 18674550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.